Table 3 Association between APCN expression and clinicopathological parameters in validation series
APCN | ||||
|---|---|---|---|---|
Low | Moderate | High | ||
n (%) | 144 | 63 | 34 | p-value |
Age. years | ||||
< 68 | 56 (38.9) | 27 (42.9) | 14 (41.2) | 0.72 |
≥ 68 | 88 (61.1) | 36 (57.1) | 20 (58.8) | |
Gender | ||||
Male | 66 (45.8) | 27 (42.9) | 20 (58.8) | 0.32 |
Female | 78 (52.4) | 36 (57.1) | 14 (41.2) | |
TNM IV | ||||
I | 28 (19.4) | 8 (12.7) | 4 (11.8) | 0.14 |
II | 51 (35.4) | 19 (30.2) | 12 (35.3) | |
III | 45 (31.3) | 25 (39.7) | 12 (35.3) | |
IV | 20 (13.9) | 11 (17.5) | 6 (17.6) | |
Grade (WHO) | ||||
1–2 | 121 (88.3) | 48 (85.7) | 30 (90.9) | 0.89 |
3–4 | 16 (11.7) | 8 (14.3) | 3 (9.1) | |
Missing | 7 | 7 | 1 | |
Side | ||||
Right | 86 (59.7) | 30 (47.6) | 17 (50.0) | 0.14 |
Left | 58 (40.3) | 33 (52.4) | 17 (50.0) | |
Histology | ||||
Non-mucinous | 128 (89.5) | 54 (85.7) | 33 (97.1) | 0.27 |
Mucinous | 15 (10.5) | 9 (14.3) | 1 (2.9) | |